Medicare Enrolled

Dr. John Leung, M.D.

Clinical & Laboratory Immunology (Allergy & Immunology) Physician · Boston, MA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
65 HARRISON AVE STE 201, Boston, MA 02111
6178046767
Registered in NPPES since 2006
NPI: 1447328711 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Leung from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Leung? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Leung

Dr. John Leung is a clinical & laboratory immunology physician in Boston, MA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Leung performed 262 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Leung received a total of $420,379 from 46 pharmaceutical and/or device companies across 951 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Leung is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ 262 Medicare services $420,379 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
262
Medicare services
Not available
Unique patients (not deduplicated)
$96
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
146 $92 $336
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
57 $133 $452
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
46 $64 $303
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
13 $95 $1,143
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$420,379
Total received (2018-2024)
Avg $60,054/year across 7 years
Top 0% in MA for clinical & laboratory immunology (allergy & immunology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
951
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$154,326
2023
$121,224
2022
$106,070
2021
$11,339
2020
$8,642
2019
$15,965
2018
$2,813

Payments by company (2024)

GENZYME CORPORATION
$64,964
Regeneron Healthcare Solutions, Inc.
$36,592
ABBVIE INC.
$21,684
Takeda Pharmaceuticals U.S.A., Inc.
$11,322
Regeneron Pharmaceuticals, Inc.
$6,004
Genentech USA, Inc.
$5,690
E.R. Squibb & Sons, L.L.C.
$4,264
Celgene Corporation
$920
AstraZeneca Pharmaceuticals LP
$765
PFIZER INC.
$380
QOL Medical, LLC
$291
Phathom Pharmaceuticals, Inc.
$284
Novartis Pharmaceuticals Corporation
$212
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$174
GlaxoSmithKline, LLC.
$168
BioCryst US Sales Co., LLC
$123
LEO Pharma Inc.
$72
Ardelyx, Inc.
$70
Blueprint Medicines Corporation
$69
Amgen Inc.
$60
Janssen Biotech, Inc.
$59
Lilly USA, LLC
$35
AIMMUNE THERAPEUTICS, INC.
$34
Celltrion USA Inc.
$34
Braintree Laboratories, Inc.
$20
Organon Llc
$20
Ferring Pharmaceuticals Inc.
$16
Top 3 companies account for 79.9% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$153,794
Regeneron Healthcare Solutions, Inc.
$136,850
Intuitive Surgical, Inc.
$33,871
ABBVIE INC.
$23,455
Takeda Pharmaceuticals U.S.A., Inc.
$20,672
Shire North American Group Inc
$9,274
Eli Lilly Export S.A. Puerto Rico Branch
$6,756
GlaxoSmithKline, LLC.
$6,313
Regeneron Pharmaceuticals, Inc.
$6,004
Genentech USA, Inc.
$5,847
E.R. Squibb & Sons, L.L.C.
$4,264
AstraZeneca Pharmaceuticals LP
$3,628
Eli Lilly and Company
$1,388
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,337
Celgene Corporation
$1,313
PFIZER INC.
$1,018
Novartis Pharmaceuticals Corporation
$843
QOL Medical, LLC
$670
CSL Behring
$308
Ardelyx, Inc.
$285
Phathom Pharmaceuticals, Inc.
$284
Amgen Inc.
$273
kaleo, Inc.
$247
Incyte Corporation
$199
BioCryst US Sales Co., LLC
$189
INTERCEPT PHARMACEUTICALS, INC.
$174
LEO Pharma Inc.
$142
ALK-Abello, Inc
$131
Janssen Biotech, Inc.
$117
AIMMUNE THERAPEUTICS, INC.
$110
Blueprint Medicines Corporation
$92
RedHill Biopharma Inc.
$83
Organon LLC
$71
Braintree Laboratories, Inc.
$68
Ironwood Pharmaceuticals, Inc
$55
Phadia US Inc.
$37
Lilly USA, LLC
$35
Celltrion USA Inc.
$34
Synergy Pharmaceuticals Inc
$25
SANOFI-AVENTIS U.S. LLC
$24
VBI Vaccines (Delaware) Inc.
$22
Organon Llc
$20
Pharming Healthcare, Inc.
$17
Ferring Pharmaceuticals Inc.
$16
USWM, LLC
$15
Boston Scientific Corporation
$14
Top 3 companies account for 77.2% of all-time payments
Associated products mentioned in payments ›
ADBRY · AIRSUPRA · AUVI-Q · AYVAKIT · BEVESPI AEROSPHERE · BREZTRI · CREON · CUVITRU · DUPIXENT · Da Vinci Surgical System · ENTYVIO · EOHILIA · EUCRISA · FASENRA · GATTEX · HADLIMA · HYQVIA · Haegarda · Hizentra · IBSRELA · ImmunoCAP · LINZESS · Linzess · MOTEGRITY · MOTOFEN · NUCALA · OCALIVA · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OMVOH · OPZELURA · ORLADEYO · Odactra · OrcaPod · PALFORZIA · PANZYGA · PREVNAR 20 · PreHevbrio · REBYOTA · RENFLEXIS · RINVOQ · RUCONEST · Ragwitek · SKYRIZI · STELARA · SUCRAID · SUFLAVE · SUPREP · SYMJEPI · Sucraid · TEZSPIRE · TRELEGY ELLIPTA · TREMFYA · TRULANCE · Talicia · Trulance · VIBERZI · VOQUEZNA · VOWST · XIFAXAN · XOLAIR · Xolair · ZENPEP · ZEPOSIA · ZYMFENTRA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a clinical & laboratory immunology physician in Boston?
Compare clinical & laboratory immunology physicians in the Boston area by procedure volume, costs, and industry payment transparency.
Browse clinical & laboratory immunology physicians nearby

Geographic Context

Clinical & laboratory immunology physicians in nearby ZIP areas
7
County median income
$92,859
Nearest hospital to ZIP centroid (approximate)
TUFTS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Leung is a clinical cardiology specialist, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Leung experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Leung performed 146 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Leung receive payments from pharmaceutical companies?
Yes. Dr. Leung received a total of $420,379 from 46 companies across 951 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Leung's costs compare to other clinical & laboratory immunology physicians in Boston?
Dr. Leung's average Medicare payment per service is $96. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Leung) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →